Näky Review

Näky in one line: an oral-drops GLP-1 specialist that keeps its prices behind the intake form

Näky (the brand runs at benaky.com) is a compounded GLP-1 telehealth platform with an unusual hook: alongside the standard injectable semaglutide and tirzepatide, it sells an oral semaglutide "drops" product and a separate GLP-1 microdose program. If you specifically want a daily oral option or a low-dose protocol and you're comfortable signing up before you see a number, Näky is built for you. If you're a careful comparison shopper who wants the monthly cost on the table before you hand over your health history, this is going to frustrate you — because Näky doesn't publish one.

How the pricing actually works (or doesn't)

This is the headline drawback, so let's be blunt about it. Näky does not post ongoing monthly pricing for its compounded semaglutide or tirzepatide anywhere on its site. Every product card — compounded tirzepatide, compounded semaglutide, the oral semaglutide drops, the microdose program, NAD+ and Sermorelin — shows a "Get Started" button and no dollar figure. When we tried to pull a pricing page directly, the URLs returned 404 errors, which tells us the gating is by design, not an oversight. You only learn what you'll pay after completing the 3-minute assessment. For context, the typical compounded GLP-1 provider in our index runs around $169 a month, so use that as your mental benchmark when Näky's quote lands — and be ready to walk if it comes in noticeably higher.

One pricing detail Näky does advertise is a flat structure: its trust bar promises "same price at every dose." That's genuinely useful, because it means you won't get hit with an escalating bill as your provider titrates you up to a therapeutic dose — a common sticker-shock moment at dose-tiered competitors. A NAKY10 promo code has been referenced for the oral semaglutide line, though it wasn't visible on our most recent check, so treat it as "ask at intake" rather than guaranteed.

The medications and how they're dispensed

Everything Näky offers is compounded — there are no brand-name GLP-1s like Wegovy or Zepbound here. The core menu is compounded semaglutide and tirzepatide by injection, plus three things that make Näky stand out from the pack:

• Oral semaglutide drops — marketed as "Daily GLP-1 Drops." This is uncommon among compounded brands and is the real reason to look at Näky. Important honesty note: these drops are NOT Rybelsus or any FDA-approved oral semaglutide, and the formulation hasn't been independently verified for dose-equivalence. Ask directly at intake how the dosing compares to an approved oral product before you commit.
• A GLP-1 microdose program — a separate, lower-dose track for people who want a gentler on-ramp or maintenance approach rather than full therapeutic dosing.
• NAD+ and Sermorelin add-ons — for patients who want to build a longevity or recovery stack on top of weight-loss treatment. Nice-to-have rather than core, but few GLP-1 sellers bundle them.

Fulfillment is through what Näky describes only as "USA-based FDA-regulated pharmacies" — and that generic phrasing is part of the problem we'll get to below. Shipping is free; the trust bar advertises 2-day delivery, though the site's own FAQ says pharmacy processing takes 2–4 business days and FedEx/UPS delivery another 3–5, so plan for closer to a week than two days.

What genuinely sets Näky apart

Strip away the marketing and Näky's real differentiator is product breadth at the formulation level. Most compounded telehealth brands give you injectable semaglutide and tirzepatide and stop there. Näky adds an oral drops line and a microdose program, which means it can serve two patient types other providers can't: needle-averse people who'd rather take a daily oral dose, and cautious starters who want to ease in with microdosing. The onboarding is also fast — a 3-minute assessment with a same-day treatment plan from a licensed, board-certified provider, and the whole thing is 100% online.

Where Näky is weak: transparency

This is the section that keeps Näky's confidence rating in the middle of the pack. Several things a discerning patient should be able to verify simply aren't disclosed:

• No named pharmacy partner — only the generic "USA-based FDA-regulated" claim, with no specific compounding pharmacy or accreditation (like 503A/503B status) named.
• No legal entity or state of incorporation — you can't easily see who actually operates the business.
• No published state-by-state availability — Näky doesn't enumerate which states it serves, and its pricing pages 404, so coverage is unclear until you sign up.
• Lab work and consult fees unclear — there's no disclosed membership fee, but whether bloodwork or a visit charge applies isn't spelled out.

None of this is a red flag on its own, and to Näky's credit it carries a verifiable LegitScript approval for benaky.com — a meaningful third-party attestation that the platform meets legitimate-pharmacy standards. We also found no FDA warning letters on file for Näky or benaky. But the combination of intake-gated pricing and an unnamed pharmacy means you're being asked to trust more on faith than the better-documented providers in our scoring methodology require.

Who should choose Näky — and who should skip it

Choose Näky if you specifically want oral semaglutide drops or a microdose protocol, you like the flat "same price at every dose" structure, and you're willing to complete a free assessment to see your quote. The fast onboarding and longevity add-ons are real perks for the right person.

Skip Näky if you want brand-name medication, if you need to confirm your state and exact monthly cost before sharing health information, or if a named, accredited pharmacy is non-negotiable for you. Patients who value upfront transparency will be happier with a provider that posts its prices and names its pharmacy.

Bottom line

Näky is a legitimate, LegitScript-approved option with a genuinely distinctive product lineup — the oral drops and microdose program are its reason to exist, and the flat dose pricing is a real plus. The catch is transparency: no public pricing, no named pharmacy, no disclosed entity or state list, and an oral formulation that isn't an FDA-approved product. If those gaps don't bother you and the oral or microdose angle is what you're after, run the free assessment and judge the quote against the roughly $169-a-month category benchmark. If you want to know exactly who and what you're buying from before you start, look elsewhere first.